The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

Completed · Phase 4 · Has a placebo group

Conditions studied: Diabetes Type 2

In brief

Subjects with type 2 diabetes will be treated with Actos or placebo for eight weeks and needle biopsies of muscle will quantify changes in any of seven different glucose transport proteins in muscle.

Key facts

Study ID

NCT01799850

Run by

East Tennessee State University

People needed

12

Starts

2002-03-01

Expected to finish

2004-03-01

Last updated by the study team

2013-02-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diabetes, type 2
• HbA1c less than 8.5

You may not qualify if…

• insulin therapy
• renal insufficiency
• clinically apparent coronary disease

Where it is running

• ETSU Quillen College of Medicine — Johnson City, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.